Hi Redant
For years now Admedus has been trying to obtain approval of Cardiocel through Australia's TGA and yet it doesn't happen.
Even a few days after last year's AGM WP went to Canberra to follow up with the TGA people and a few weeks later I recall there was a release of Cardiocell performance data ...... BUT ..... approval is not forthcoming.
Do you have any idea why not? What is their area of concern?
.
What are the positives?, page-12
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.29 |
Change
0.290(3.22%) |
Mkt cap ! $188.6M | |||
| Open | High | Low | Value | Volume |
| $9.00 | $9.29 | $9.00 | $36.93K | 4.018K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 10930 | $9.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.38 | 1000 | 1 |
View Market Depth
| Last trade - 15.45pm 31/01/2025 (20 minute delay) ? |
| AVR (ASX) Chart |